Saroja Pharma Industries
SAROJA NSE
Saroja Pharma Industries
CommoditiesNSE: SAROJA Chemicals & Petrochemicals
Key Fundamentals
SMESpecialty ChemicalsChemicalsMarket Cap
₹16.00 Cr
Volatility
Moderate
P/E Ratio
9.9
EBITDA
₹3.70 Cr
Return on Equity
6.6%
Debt to Equity
0.83
Book Value
₹43.01
52W High
₹48
52W Low
₹28
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Stock is trading at 0.93 times its book value
- Debtor days have improved from 139 to 89.9 days.
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 8.50% over last 3 years.
Growth Rate
Revenue Growth
30.11% higher than
3Y
Net Income Growth
62% higher than
3Y
Cash Flow Change
12.75% higher than
3Y
ROE
10% lower than
3Y
ROCE
9.05% higher than
3Y
EBITDA Margin (Avg.)
-4.17% higher than
3Y
Quarterly Results
| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 26.54 | 23.73 | 21.12 | 19.36 | 18.79 | 35.11 | 38.76 | 31.47 |
| Expenses | 25.18 | 22.28 | 19.95 | 18.17 | 17.58 | 33.34 | 37.39 | 29.04 |
| Operating Profit | 1.36 | 1.45 | 1.17 | 1.19 | 1.21 | 1.77 | 1.37 | 2.43 |
| OPM % | 5.12% | 6.11% | 5.54% | 6.15% | 6.44% | 5.04% | 3.53% | 7.72% |
| Other Income | 0.08 | 0 | 0.39 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.68 | 0.64 | 0.83 | 0.62 | 0.69 | 0.72 | 0.53 | 0.93 |
| Depreciation | 0 | 0.07 | 0.04 | 0.06 | 0.05 | 0.06 | 0.06 | 0.05 |
| PBT | 0.76 | 0.74 | 0.69 | 0.51 | 0.47 | 0.99 | 0.78 | 1.45 |
| Tax % | 27.63% | 27.03% | 27.54% | 27.45% | 27.66% | 29.29% | 26.92% | 28.28% |
| Net Profit | 0.55 | 0.54 | 0.5 | 0.38 | 0.34 | 0.7 | 0.57 | 1.04 |
| EPS in Rs | 24.36 | 1.84 | 1.24 | 0.95 | 0.85 | 1.74 | 1.42 | 2.59 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 36.66 | 55.63 | 50.19 | 40.67 | 53.73 | 70.24 |
| Expenses | 35.36 | 53.53 | 47.47 | 38.11 | 50.95 | 66.43 |
| Operating Profit | 1.3 | 2.1 | 2.72 | 2.56 | 2.78 | 3.81 |
| OPM % | 3.55% | 3.77% | 5.42% | 6.29% | 5.17% | 5.42% |
| Other Income | 0.09 | 0.32 | 0.16 | 0.19 | 0.19 | 0 |
| Interest | 0.33 | 0.8 | 1.32 | 1.45 | 1.41 | 1.46 |
| Depreciation | 0.02 | 0.05 | 0.07 | 0.09 | 0.11 | 0.11 |
| PBT | 1.04 | 1.57 | 1.49 | 1.21 | 1.45 | 2.24 |
| Tax % | 28.85% | 28.03% | 28.86% | 27.27% | 28.97% | 27.68% |
| Net Profit | 0.73 | 1.14 | 1.06 | 0.88 | 1.03 | 1.62 |
| EPS in Rs | 730 | 50.49 | 3.61 | 2.19 | 2.56 | 4.03 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.23 | 2.94 | 4.02 | 4.02 | 4.02 |
| Reserves | 0.93 | 3.8 | 2.15 | 10.62 | 11.66 | 13.27 |
| Borrowings | 3.02 | 6.14 | 10.18 | 5.73 | 9.46 | 14.41 |
| Other Liabilities | 4.26 | 5.34 | 6.07 | 6.2 | 14.41 | 10.05 |
| Total Liabilities | 8.22 | 15.51 | 21.34 | 26.57 | 39.55 | 41.75 |
| Fixed Assets | 0.09 | 0.34 | 2.22 | 2.51 | 2.51 | 2.18 |
| CWIP | 0 | 0 | 1.79 | 6.13 | 8.61 | 20.34 |
| Investments | 0 | 0.04 | 0.14 | 0.2 | 0.34 | 0.54 |
| Other Assets | 8.13 | 15.13 | 17.19 | 17.73 | 28.09 | 18.69 |
| Total Assets | 8.22 | 15.51 | 21.34 | 26.57 | 39.55 | 41.75 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | -1.05 | -3.67 | 2.19 | 1.02 | 1.15 | 7.44 |
| Investing | -0.05 | -0.34 | -4.82 | -4.76 | -2.7 | -11.68 |
| Financing | 1.03 | 4.27 | 2.73 | 3.7 | 1.56 | 4.25 |
| Net Cash Flow | -0.07 | 0.26 | 0.1 | -0.04 | 0.01 | 0.01 |
| Free Cash Flow | -1.1 | -3.97 | -1.54 | -3.71 | -1.45 | -4.06 |
| CFO/OP | -58 | -154 | 96 | 53 | 56 | 212 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 71.88 | 91.73 | 80.8 | 146 | 181 | 89.9 |
| Inventory Days | 7.23 | 3.41 | 31.18 | 4.1 | 0.75 | 4.92 |
| Days Payable | 45.43 | 38.52 | 47.22 | 57.45 | 103 | 48.43 |
| Cash Conversion Cycle | 33.68 | 56.62 | 64.76 | 92.39 | 78.76 | 46.38 |
| Working Capital Days | 22.2 | 33.07 | 17.16 | 71.71 | 29.89 | 5.87 |
| ROCE % | — | 33.55% | 22.09% | 14.93% | 12.57% | 13.02% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Saroja Pharma Industries insights
51 extracted metrics + investor summaries across FY21–FY26.
Documents
1
Copy of Newspaper Publication
9 Sep - Newspaper advertisement published for 8th AGM notice and e-voting information on 30 September 2026. 9 Sep - Newspaper advertisement published for 8th AGM notice and e-voting information on 30 September 2026.
2
Outcome of Board Meeting
7 Sep - Board approved FY26 Board Report, MD&A and 8th AGM notice. 7 Sep - Board approved FY26 Board Report, MD&A and 8th AGM notice.
3
Shareholders meeting
7 Sep - 08th AGM on 30 Sep 2026; shareholders to approve financials and director appointments. 7 Sep - 08th AGM on 30 Sep 2026; shareholders to approve financials and director appointments.
4
Price movement
28 Aug - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written … 28 Aug - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …
5
Outcome of Board Meeting
22 Aug - Board re-designates Mr. Pulinattu Nandakumar as Whole-time Director; appoints Mr. Niraj Variava Internal Auditor for FY27. 22 Aug - Board re-designates Mr. Pulinattu Nandakumar as Whole-time Director; appoints Mr. Niraj Variava Internal Auditor for FY27.
Frequently Asked Questions about Saroja Pharma Industries
What does Saroja Pharma Industries India Ltd do?
Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]
Where is Saroja Pharma Industries India Ltd (SAROJA) listed?
Saroja Pharma Industries India Ltd trades as SAROJA on the NSE.
Which sector does Saroja Pharma Industries India Ltd belong to?
Saroja Pharma Industries India Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.
What is the market capitalisation of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd has a market capitalisation of ₹16 Cr, which places it in the Small Cap band.
What is the PE ratio of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd trades at a PE ratio of 9.90, against a book value of ₹43.01 per share.
What is the 52-week high and low of Saroja Pharma Industries India Ltd?
Over the last 52 weeks Saroja Pharma Industries India Ltd has traded between ₹28 and ₹48.
What is the Return on Equity (ROE) of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd reported a return on equity of 6.60%. Its debt-to-equity ratio is 0.83.
Company Information
Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SAROJA.md for Saroja Pharma Industries India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.